Grey Fox Wealth Advisors, LLC Gilead Sciences, Inc. Transaction History
Grey Fox Wealth Advisors, LLC
- $491 Billion
- Q3 2025
A detailed history of Grey Fox Wealth Advisors, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Grey Fox Wealth Advisors, LLC holds 2,126 shares of GILD stock, worth $263,815. This represents 0.05% of its overall portfolio holdings.
Number of Shares
2,126
Previous 2,130
0.19%
Holding current value
$263,815
Previous $236 Million
0.07%
% of portfolio
0.05%
Previous 0.06%
Shares
10 transactions
Others Institutions Holding GILD
# of Institutions
2,367Shares Held
1.01BCall Options Held
8.63MPut Options Held
7.39M-
Black Rock Inc. New York, NY121MShares$15 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$14.8 Billion0.21% of portfolio
-
State Street Corp Boston, MA59.1MShares$7.33 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA45.2MShares$5.61 Billion0.72% of portfolio
-
Dodge & Cox San Francisco, CA30.1MShares$3.74 Billion1.93% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $156B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...